In this study, we used scRNA-seq to reveal the molecular features of the TME of HER2 + IBC and performed a comprehensive and detailed comparison of the molecular phenotypes of tumour cells, mesenchymal cells, myeloid cells, T cells, B cells, and antibody-secreting cells between IBC and nIBC patients. This evidence concerns the gene ERBB2 and neoplasm.